Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 785 of 6351
-
A digital nudge: could a tailored online tool boost weight loss program enrollment?
Disease control By invitation onlyThis study will test the effects of a brief, individually tailored intervention aiming to increase initiation of comprehensive behavioral weight loss treatment on weight.
Sponsor: University of Florida • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New drug shows promise for Sjögren's sufferers
Disease control OngoingPrimary Objective: To evaluate the effect of dazodalibep on systemic manifestations of Sjögren's Syndrome (SS) in participants with moderate-to-severe systemic disease activity. Secondary Objectives: 1. To evaluate the effect of dazodalibep on patient reported outcomes (PROs) …
Phase 3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Could a common supplement shield the aging brain from metabolic stress?
Disease control CompletedThe aim of the study is to investigate the effects of coenzyme Q10 supplementation (150 mg twice daily; 300 mg/day for 12 weeks) on coenzyme Q10 status, glucose parameters, BDNF, myokines, and cognitive function in patients with mild cognitive impairment (MCI) or Alzheimer's dise…
Sponsor: Chung Shan Medical University • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New shot could free kids with HIV from daily pills
Disease control Recruiting nowThe purpose of the study is to evaluate the pharmacokinetics (PK), safety, tolerability, and acceptability of a long-acting injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living with HIV-1, Two to Less Than 12 Years of Age
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New CAR t therapy targets hidden leukemia cells in adults
Disease control Recruiting nowThis open-label, single arm Phase 1/1b trial aims to determine the safety and tolerability of anti-CD19 chimeric antigen receptor-expressing (CAR) T cells (UCD19 CAR T) in adults with B-ALL that are in first complete remission with MRD positivity. This trial will enroll 10 patien…
Phase 1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Supercharged immune cells aim to stop leukemia relapse
Disease control Recruiting nowThe purpose of this research study is to test the safety and efficacy of cytokine induced memory-like (CIML) natural killer (NK) cells expanded with Interleukin-2 (IL-2) at preventing relapse in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or MDS and myeloprolife…
Phase 1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New Antibody-Drug conjugate targets Hard-to-Treat cancers
Disease control Recruiting nowThis is a phase I, open-label, first-in-human clinical study designed to evaluate the safety, tolerability, MTD, DLT, RP2D, the PK characteristics, preliminary anti-tumor activity, the immunogenicity of DXC006 in patients with a variety of solid tumors, including small cell lung …
Phase 1 • Sponsor: Hangzhou DAC Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New hope for advanced bladder cancer: experimental drug combo enters late-stage trial
Disease control OngoingThis is a global, multicenter, randomized, open-label study. The main objective of the study is to measure the clinical activity and safety of zelenectide pevedotin formally BT8009, in combination with pembrolizumab versus chemotherapy, and as monotherapy in participants with loc…
Phase 2 • Sponsor: BicycleTx Limited • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug combo shows promise for incurable blood cancer
Disease control OngoingThis phase II trial tests how well lenalidomide and epcoritamab works in treating patients with follicular lymphoma that has not been previously treated. Although follicular lymphoma is incurable, prognosis has improved for both early and advanced stage disease, largely attribute…
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New combo therapy targets hard-to-treat liver metastases in colorectal cancer
Disease control CompletedHepatic arterial infuison chemothearpy (HAIC), targeted therapy, and programmed death-1 (PD-1) inhibitors have been demonstrated to be effective for colorectal cancer liver metastasis (CRCLM). Thus, the investigators will conduct a prospective trial to explore the efficacy and sa…
Sponsor: Peking University • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New drug combo shows promise in shrinking breast cancer before surgery
Disease control CompletedPREcoopERA is a randomized (2:2:1), multicenter, open-label, three-arm (A, B, C), Window-of-Opportunity (WOO) trial to evaluate the activity and safety of giredestrant (A) versus giredestrant plus triptorelin (B) versus anastrozole plus triptorelin (C).
Phase 2 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New weekly shot could boost growth in babies with dwarfism
Disease control Recruiting nowThis trial is a Phase 2, multicenter, double-blind, randomized (ratio 2:1 TransCon CNP vs. placebo), placebo-controlled trial, designed to evaluate the safety, tolerability, and efficacy of 100 μg CNP/kg of Navepegritide (TransCon CNP) administered SC once-weekly for 52 weeks in …
Phase 2 • Sponsor: Ascendis Pharma A/S • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New hope for transplant patients: drug combo targets debilitating GVHD
Disease control OngoingThis is a parallel, Phase 3, two-arm study for the treatment of newly diagnosed moderate or severe chronic GVHD. The study duration for a participant includes up to 4 weeks for screening; a treatment period until clinically meaningful cGVHD progression (defined as progression re…
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New Dual-Targeting CAR t therapy takes on Hard-to-Treat myeloma
Disease control Recruiting nowThe purpose of this study is to assess BMS-986453 in participants with relapsed and/or refractory multiple myeloma (RRMM).
Phase 1 • Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Could your own cells fight parkinson? new brain implant trial begins
Disease control By invitation onlyThis clinical trial is designed to test the safety and tolerability of injecting ANPD001 cells that will mature into dopamine-producing cells into the brain of participants with Parkinson Disease. All participants will have ANPD001 cells manufactured from their own previously col…
Phase 1 • Sponsor: Aspen Neuroscience • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug combo shows promise against advanced cervical cancer in early trial
Disease control OngoingThis is an investigator-initiated, single-arm, phase II clinical study evaluating the efficacy and safety of cadonilimab combined with induction chemotherapy followed by concurrent chemoradiotherapy (CCRT) in patients with locally advanced cervical cancer (LACC). Despite standard…
Phase 2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Pre-surgery workouts may boost lung cancer recovery
Disease control Recruiting nowThe goal of this clinical trail is to compare the effects of preoperative exercise training of different intensities on short-term cardiorespiratory function and postoperative outcomes in patients scheduled for lung resections.
Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Simple mouth swab could spot hidden throat cancer early
Diagnosis Recruiting nowInvestigators seek to determine the sensitivity and specificity of a combined HPV 16 DNA and host gene methylation oral biomarker panel to distinguish early Oropharyngeal Cancer (OPC) cases from controls among 100 early and 100 late disease pre-treatment OPC cases, and 200 contro…
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
New radiation approach may offer shorter, safer treatment for recurrent prostate cancer
Disease control Recruiting nowThis phase III trial tests the side effects of stereotactic body radiation therapy (SBRT) compared to hypofractionated radiotherapy for treating patients with prostate adenocarcinoma that has come back after a period of improvement (recurrent) or that has spread from where it fir…
Phase 3 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could a diabetes drug shield kidneys in lupus?
Disease control Recruiting nowSystemic lupus erythematosis (SLE) is a chronic, most probably auto-immune multisystem disease marked by relapsing-remitting course and the formation of a range of autoantibodies. SLE patients present with serious renal (lupus nephritis (LN)), cardiopulmonary, or nervous manifest…
Phase 4 • Sponsor: Ahmed Yehia Ismail • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC